Amyris has developed genetic an industrial synthetic biology platform (genetic engineering technologies) that enables modification of the sugar metabolic pathways in  microbes, primarily yeast. This technology enables Amyris to design living factories that convert plant-sourced sugars from crops such as sugarcane or sweet sorghum into target molecules.